Intrauterine correction of obstructive uropathies by bilateral nephroamnial bypass grafting of the fetal kidneys


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

Background. Renal dysplasia is a major cause of chronic renal failure in infants and is commonly associated with urinary tract obstruction. The presence of grades III-IV hydronephrosis or pathology of the posterior urethral valves in the fetus is known to be a prognostically unfavorable sign for the life and health of newborn infants and an indication for intrauterine correction. Vesicoamnial bypass grafting is the most commonly used method to correct infravesicular obstruction in clinical practice. However, there are other surgical procedures. As of now, the Ural Research Institute of Maternal and Infant Care, Ministry of Health of the Russian Federation, has introduced the nephroamnial bypass grafting for decompression of the fetal urinary tract, which reduces the risk of fetal complications (stent occlusion or expulsion) and improves prognosis, survival, and preservation of normal renal function. Intrauterine bypass grafting of the renal cavitary system is a pathogenetically justif ied treatment and is applicable to all types of urinary system obstruction in the fetus. Case report. The paper describes three cases of bilateral nephroamnial bypass grafting of the fetal kidneys, by using the SDE-MED 3.0Fr/50mm stent with its original shape of pigtails, which has been designed at the Ural Research Institute of Maternal and Infant Care, Ministry of Health of the Russian Federation (Useful Model Patent for Endoprosthesis Stent under No. 152166 dated April 13, 2015). Conclusion. The minimally invasive fetal kidney bypass grafting method developed and introduced into clinical practice allows the use of a shorter stent with its original pigtail shape, which provides its more reliable fixation in the fetal renal cavitary system. The bilateral bypass grafting technique ensures adequate urodynamics in both fetal kidneys, maintaining the normal function of the affected organs, preventing the formation of the secondarily contracted kidneys, thereby eliminating the unfavorable outcome of urinary system diseases in newborns. Both maternal and fetal complications of intrauterine interventions were not recorded.

全文:

受限制的访问

作者简介

Natalya Kosovtsova

Ural Research Institute of Maternal and Infant Care, Ministry of Health of the Russian Federation

Email: kosovcovan@mail.ru
MD, Head of the Department of Biophysical Research Methods, doctor of the highest category

Maria Pavlichenko

Ural Research Institute of Maternal and Infant Care, Ministry of Health of the Russian Federation

Email: pavlichenko-mariya@mail.ru
candidate of medical sciences, Head of the Department of Young Children, pediatrician of the highest category

Roman Makarov

Ural Research Institute of Maternal and Infant Care, Ministry of Health of the Russian Federation

Email: r_makarov_ekb@mail.ru
Ph.D., Head of the Department of Anesthesiology and Resuscitation, senior researcher at the Intensive Care Unit

Yana Pospelova

Ural Research Institute of Maternal and Infant Care, Ministry of Health of the Russian Federation

Email: jana.pospelova@yandex.ru
doctor of ultrasound diagnostics, postgraduate student

Vladislav Chudakov

Ural Research Institute of Maternal and Infant Care, Ministry of Health of the Russian Federation

pediatric neurosurgeon, surgeon of the highest qualification category, Honored Doctor of the Russian Federation

Aleksey Breynik

Ural Research Institute of Maternal and Infant Care, Ministry of Health of the Russian Federation

Email: leostinovich@yandex.ru
anesthesiologist-resuscitator of the Department of Anesthesiology and Intensive Care

参考

  1. Айламазян Э.К., Баранов В.С., ред. Пренатальная диагностика наследственных и врожденных болезней. М.: МЕДпресс-информ; 2006; 416 c. [Ailamazyan E.K., Baranov V.S., ed. Prenatal diagnosis of hereditary and congenital diseases. M.: MEDpress-inform. 2006; 416 p. (in Russian)].
  2. Молчанова Е.А., Валов А.Л., Каабак М.М. Первые результаты формирования Российского регистра хронической почечной недостаточности у детей. Нефрология и диализ. 2003; 5(1): 64-8. [Molchanova E.A., Valov A.L., Kabaak M.M. The first results of the formation of the Russian Register of chronic renal failure in children. Nephrology and dialysis. 2003; 5(1): 64-8. (in Russian)].
  3. Bernstein J. Developmental abnormalities of the renal parenchyma-renal hypoplasia and dysplasia. Pathol. Annu. 1958; 3: 213-47.
  4. Zimmermann R., Huch A. A large unilateral contained urinoma in a fetus: an indication for intrauterine urinary shunting. Fetal Diagn. Ther. 1993; 8(4): 26872. https://dx.doi.org/10.1159/000263838.
  5. Wu S., Johnson M.P. Fetal lower urinary tract obstruction. Clin. Perinatol. 2009; 36(2): 377-90. https://dx.doi.org/10.1016/j.clp.2009.03.010.
  6. Kilby M., Khan K., Morris K, Daniels J., Gray R., Magill L. et al. PLUTO trial protocol: percutaneous shunting for lower urinary tract obstruction randomised controlled trial. BJOG. 2007; 114(7): 904-5, e1-4. https://dx.doi.org/10.1111/ j.1471-0528.2007.01382.x.
  7. Kilby M., Morris R. The PLUTO trial: percutaneous shunting in lower urinary tract obstruction. Am. J. Obstet. Gynecol. 2012; 206(1, Suppl.): S14. https:// dx.doi.org/10.1016/j.ajog.2011.10.044.
  8. Miller S. Fetal lower urinary tract obstruction: an update russell. Open Urol. Nephrol. J. 2015; 8(Suppl. 3: M6): 124-35. https://dx.doi.org/10.2174/187430 3x015080100124.
  9. Morris R.K., Malin G.L., Quinlan-Jones E., Middleton L.J., Hemming K., Burke D. et al. Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Lancet. 2013; 382(9903): 1496-506. https://dx.doi.org/10.1016/s0140-6736(13)60992-7.
  10. Morris R.K., Khan K.S., Kilby M.D. Vesicoamniotic shunting for fetal lower urinary tract obstruction: an overview. Arch. Dis. Child. Fetal Neonatal Ed. 2007; 92(3): F166-8. https://dx.doi.org/10.1136/adc.2006.099820.
  11. Косовцова Н.В., Маркова Т.В., Башмакова Н.В., Чистяков М.А. Шунтирование почек плодов в эксперименте на животных. Экспериментальная и клиническая урология. 2017; 2: 20-5. [Kosovtsova N.V., Markova T.V., Bashmakova N.V., Chistyakov M.A. Shunting of fetal kidneys in an animal experiment. Experimental and clinical urology. 2017; 2: 20-5. (in Russian)].
  12. Kosovtsova N.V., Bashmakova N.V., Pavlichenko M.V., Markova T.V., Shabunina-Basok N.P., Izmestieva K.A. Development of the stent for nephroamniotic shunting. Donald School Journal of Ultrasound in Obstetrics and Gynecology. 2018; 12(1): 13-6. https://dx.doi.org/10.5005/jp-journals-10009-1547.
  13. Biard J.M., Johnson M.P., Carr M.C., Wilson R.D., Hedrick H.L., Pavlock C., Adzick N.S. Long-term outcomes in children treated by prenatal vesicoamniotic shunting for lower urinary tract obstruction. Obstet. Gynecol. 2005; 106(3): 503 8. https://dx.doi.org/10.1097/01.AOG.0000171117.38929.eb
  14. Kitchens D.M., Anthony C.D. Prenatal intervention for lower urinary tract obstruction. Scientific World Journal. 2009; 9: 390-2. https://dx.doi.org/1100/ tsw.2009.49

补充文件

附件文件
动作
1. JATS XML

版权所有 © Bionika Media, 2020
##common.cookie##